Molecular basis of host-pathogen interaction in septic shock (Q33538538)

27 July 2017

1 reference

title

Molecular basis of host-pathogen interaction in septic shock (English)

1 reference

27 July 2017

0 references

1 reference

Heumann D

1 reference

27 July 2017

Glauser MP

series ordinal

1 reference

27 July 2017

Calandra T

series ordinal

1 reference

27 July 2017

publication date

1 February 1998

1 reference

Current Opinion in Microbiology

27 July 2017

published in

1 reference

27 July 2017

1 reference

27 July 2017

1 reference

27 July 2017

page(s)

49-55

1 reference

T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Molecular structure of staphylococcus and streptococcus superantigens.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

CD14 is a pattern recognition receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Coexistence of CD14-dependent and independent pathways for stimulation of human monocytes by gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Glycosphingolipids from Sphingomonas paucimobilis induce monokine production in human mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Time course of cytokine levels in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

The biologic activities of peptidoglycan in experimental Haemophilus influenzae meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Penetration of the blood-brain barrier: enhancement of drug delivery and imaging by bacterial glycopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Release of cytokines induced by Salmonella typhimurium porins.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Relative cytokine-stimulating activities of surface components of the oral periodontopathogenic bacterium Actinobacillus actinomycetemcomitans

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Stimulation of human monocytes by endotoxin-associated protein: inhibition of programmed cell death (apoptosis) and potential significance in adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Induction of Th1 cytokine responses by mycobacterial antigens in leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

In Vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Cytokine gene expression in human peripheral blood mononuclear cells stimulated by mannoprotein constituents from Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Lipopolysaccharide/Lipid a Receptors on Lymphocytes and Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Binding of lipopolysaccharide (LPS) to an 80-kilodalton membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Characterization of binding and TNF-alpha-inducing ability of chitosans on monocytes: the involvement of CD14

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

The involvement of CD14 in stimulation of cytokine production by uronic acid polymers

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

CDP571, a humanized antibody to human tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

Cellular binding of soluble CD14 requires lipopolysaccharide (LPS) and LPS-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980142-2

7 January 2021

10.1016/S1369-5274(98)80142-2

Identifiers

DOI

1 reference

27 July 2017

1 reference